Which patients are prescribed inhaled anti-asthma drugs?

Roberts, S J; Bateman, D N
November 1994
Thorax;Nov1994, Vol. 49 Issue 11, p1090
Academic Journal
No abstract available.


Related Articles

  • Targeting Drugs to the Airways by Different Inhalation Devices: Role of Deposition Characteristics. Lotvall, J.; Obyrne, P. // BioDrugs;1999, Vol. 12 Issue 4, p279 

    Inhalation therapy has greatly improved the treatment of asthma over the last decades. In recent years, inhalation technology has further optimised the local deposition of inhaled antiasthma drugs. Some studies have suggested improved clinical efficacy, and possibly tolerability, of drugs given...

  • Utilization, Spending, and Price Trends for Short- and Long-Acting Beta-Agonists and Inhaled Corticosteroids in the Medicaid Program, 1991-2010. Shih-Feng Chiu; Kelton, Christina M. L.; Guo, Jeff Jianfei; Wigle, Patricia R.; Lin, Alex C.; Szeinbach, Sheryl L. // American Health & Drug Benefits;Jun2011, Vol. 4 Issue 3, p140 

    Background: Asthma is a chronic respiratory disease that afflicts millions of people and accounts for substantial utilization of healthcare resources in most industrialized countries, including in the United States. However, the exact cost and utilization of anti-asthma medications in Medicaid...

  • CFC inhalers zoned out.  // Drug Topics;4/21/97, Vol. 141 Issue 8, p8 

    Announces Schering-Plough Corp.'s offering of the anti-asthma drug Proventil HFA (albuterol sulfate) in a chlorofluorocarbon-free inhaler. Drawbacks of old inhalers.

  • Recent Development of Drug Delivery Systems for the Treatment of Asthma and Related Disorders. Takizawa, Hajime // Recent Patents on Inflammation & Allergy Drug Discovery;Nov2009, Vol. 3 Issue 3, p232 

    It is well established that airway inflammatory processes are pivotal as the pathological features of asthma. Prominent infiltration of eosinophils and Th2 lymphocytes is a hallmark of the allergic inflammation, and inhaled corticosteroids markedly suppress such inflammatory changes, resulting...

  • Drug prescription pattern for asthma among nigerian doctors in general practice: A cross-sectional survey. Fawibe, Ademola E.; Onyedum, Cajetan C.; Sogaolu, Olumide M.; Ajayi, A.O.; Fasae, A.J. // Annals of Thoracic Medicine;Apr-Jun2012, Vol. 7 Issue 2, p78 

    BACKGROUND: A wide range of medications are now available for the treatment of asthma and selection of the optimal treatment combination of agents is essential. OBJECTIVES: This study was designed to evaluate a self-reported drug prescribing pattern for asthma among Nigerian doctors in general...

  • ASTHMA TREATMENTS: INHALATIONS.  // Monthly Prescribing Reference;Dec2014, Vol. 30 Issue 12, p278 

    A table is presented which provide information on the strength, form, and dosage of several anti-asthma drugs including ipratropium bromide, albuterol sulfate, and levalbuterol tartrate.

  • Management of the chest in cystic fibrosis. Dinwiddie, R. // Journal of the Royal Society of Medicine (Supplement);Jan1986, Vol. 79 Issue 12, p6 

    The article focuses on the importance of adequate care of the chest in the management of a patient with cystic fibrosis (CF). The role of allergy in lung disease is discussed, as well as the regular surveillance of the CF patient. The modes of lung management can be grouped into pulmonary...

  • Patients, physicians face CFC-HFA switch deadline. DeArment, Alaric // Drug Store News;12/8/2008, Vol. 30 Issue 15, p42 

    The article reports on the plan of Food and Drug Administration to phase out CFC-propelled albuterol inhalers and adopted the regulations in May, which will take effect at the end of 2008 in New York. The author stated that the regulations require doctors to start prescribing inhalers that use...

  • Reminder about ICS prescribing. Cameron, Amanda // New Zealand Doctor;6/18/2008, p23 

    The article focuses on a reminder made by Auckland, New Zealand-based respiratory expert Jeff Garrett that local general practice physicians (GP) should monitor the inhaled steroid they are prescribing in the aftermath of two overseas studies revealing inappropriate use of the drugs. These...

  • Age- and gender-specific asthma death rates in patients taking long-acting beta2-agonists: prescription event monitoring pharmacosurveillance studies. Martin, R.M.; Shakir, S. // Drug Safety;Apr2001, Vol. 24 Issue 6, p475 

    Objective: Prescription event monitoring is a national drug safety surveillance scheme in which prescribers are prompted to report events and deaths following prescription of newly marketed drugs. This paper presents age- and gender-specific asthma death rates in patients prescribed...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics